Propel Bio Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-165,000	Closed	-$5.87M	–	31
2023 Q4	$5.87M	Buy	+165,000	New	+$5.87M	4.87%	5